Warm biotech welcome for £150 million Innovation Fund The UK Government’s plans to create a new £150 million fund to promote innovation has received enthusiastic support from leading lights in the country’s life science industry
AstraZeneca's Iressa approved in Europe AstraZeneca's almost-forgotten oncology agent Iressa has been approved in Europe for the treatment of certain patients suffering from non-small cell lung cancer
BMA urges government: “abandon the NHS market” There has never been a better time to end the “ludicrous, divisive and expensive experiment of the market in healthcare in England,” the British Medical Association (BMA) has told the new Health Secretary, Andy Burnham.
Shock move from Roche as it severs ties with ABPI In a shock move Swiss drugmaker Roche has decided not to renew its membership of the Association of the British Pharmaceutical Industry, putting a question mark over the viability of self-regulation in the UK.
